This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
There have been a number of interesting entries since I have been away on THE NEW PROSTATE CANCER INFOLINK Those of you who haven’t bookmarked the Infolink site or signed up for the site so you get reminders direct might find these worth reading.
-- Can CAPRA scores predict risk of metastasis and death at diagnosis?
-- Do PSA dynamics enhance pretreatment prediction of outcome — or not?
-- A word to our congressional representatives
-- Socioeconomic status, race, and prostate cancer — the view from California
-- From hormone-sensitive to hormone-refractory: how does it happen?
-- 15-year outcomes after radical prostatectomy: a new predictive model
-- How early can PSA doubling times tell what?
-- Mass screening and stage migration: a UK analysis
